Breakthrough as Uppsala University discover structures in brain cancer patients found to help fight tumors

SWEDEN – Researchers at Uppsala University have discovered lymph node-like structures close to the tumor in brain cancer patients, where immune cells can be activated to attack the tumor. In the study now published in the journal Nature Communications, the researchers describe their discovery of structures similar to lymph nodes in the brain where T lymphocytes(major components of the adaptive immune system that kill infected host cells) could be activated. The research was conducted on glioma- bearing mice and showed that the formation of tertiary lymphoid structures (TLS), ectopic lymphoid…

Read More

World Health Organization commits to advocate for women empowerment and health

SWITZERLAND – Following the General Equality Forum held last week in France, the world Health Organization (WHO) pledged it would commit to drive change for gender equality and the empowerment of women and girls in all their diversity. WHO said the newly formed task force will be committed to ending gender-based violence, advancing sexual & reproductive health & rights, and supporting health workers as well as feminist movements and leadership. The organization will partner with Wellspring, Ford Foundation, UN Women and the Government of the United Kingdom, in the launch…

Read More

Swift medical partners with Accentcare as it aims to venture into the home-based health market

CANADA – Digital wound care start-up Swift Medical is partnering with one of the largest home health providers, AccentCare, to get its technology into the hands of thousands of care providers in moves to secure a bigger share of the home health market. Post-acute healthcare company AccentCare serves more than 210,000 individuals across 31 states and plan to use Swift Medical’s digital wound management platform to improve care for the highest complexity wound patients in the home. Swift Medical’s technology is able to capture wound care information by waving the…

Read More

Nordic Oil subsidiary of Nordic health group BV launches first ever equity crowdfunding campaign

GERMANY – Nordic Health Group BV (Nordic Oil), the popular European CBD manufacturer, has launched its equity crowdfunding campaign on Seedrs, a UK-based crowdfunding platform. Running throughout July, the campaign marks the first time Nordic Oil has taken in external investments in its three-year history. With this milestone campaign, the company aims to generate funds that will be used to further the business’ expansion into new and emerging markets. This campaign launched in partnership with Seedrs will see the Nordic Group aim to bring the benefits of its hugely popular…

Read More

Franco Valle appointed chief financial officer at Biomea fusion in move to strengthen company’s executive team

USA – Biomea Fusion, a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, announced the appointment of Franco Valle as Chief Financial Officer. Mr. Valle is an accomplished financial expert who brings extensive experiences to Biomea, in particular with building the necessary infrastructure to support clinical and operational growth within biotech companies. He will assume the financial leadership from Sunny Lee who has served at that role since September2020. Recently, Mr. Valle served as Principal Accounting Officer &…

Read More

Michael Klobuchar appointed for newly created role of chief strategy officer at Merck

US – Michael Klobuchar has been appointed executive vice president and chief strategy officer of Merck as he will also become a member of Merck’s Executive Committee and lead the advancement and execution of the company’s strategy. At the time of his appointment, Klobuchar was senior vice president of Merck Research Laboratories Finance and Global Project and Alliance Management, he also previously served as the company’s senior vice president, Corporate Strategy and Financial Planning, and president, Merck Global Health Innovation Fund. Klobuchar has a Bachelor of Science degree in Chemical…

Read More

GSK unveils new portfolio and strategy, set to specialize on vaccines and medicines in a bid to grow its market scope

UK – GlaxoSmithKline (GSK), one of British pharmaceutical giants has updated its strategy, outlook and growth plans on its vaccines and specialty medicine portfolio as it is set to split its consumer healthcare and pharmaceutical businesses in mid-2022. GSK will now prioritize R&D and investment in vaccines and speciality medicines, which are expected to grow to around three-quarters of the company’s sales by 2026. The British drug maker said it will also ‘optimise’ various therapies, with a newly defined product group containing all of new GSK’s primary care brands. In…

Read More

Pete Arduini appointed president and Chief Executive Officer of GE healthcare

US – GE has announced appointment of Pete Arduini as president and Chief Executive Officer of GE Healthcare effective January 3, 2022. Arduini will succeed Kieran Murphy who will continue to serve in his current role until the end of 2021 after which he will serve as a strategic advisor to GE before retiring from the Company. Arduini joins GE from Integra LifeScience where he has served as president and CEO since January 2012. Under his leadership, the Integra LifeSciences portfolio has evolved significantly to a faster growing and more…

Read More

CureVac’s vaccine proves to have a 47% efficacy rating after its preliminary results

EUROPE – The German company CureVac provided disappointing preliminary results from a clinical trial of its COVID-19 vaccine, dimming hopes that it could help fill the world’s current greatest need. The trial, which included 40,000 volunteers in Latin America and Europe, estimated that CureVac’s mRNA vaccine had an efficacy of just 47 percent, among the lowest reported so far from any COVID-19 vaccine maker. Results released were based on data from 135 volunteers who got sick with COVID-19 as an independent panel compared the number of sick people who had…

Read More

Bayer’s Astepro approved for over the counter use in the US

US – The US Food and Drug Administration (FDA) has approved Bayer’s steroid-free antihistamine nasal spray Astepro for over-the-counter use. Astepro becomes the first and only OTC steroid-free antihistamine nasal spray available in the US for adults and children aged six years and older. Currently, OTC allergy medications is classified into three major classes which include antihistamines, intranasal steroids and mast cell stabilizers. Bayer, a German multinational pharmaceutical and life sciences company had astepro previously approved for prescription use in 2008. Following the approval by the FDA, Astepro will be…

Read More